Sentences with phrase «epipens after»

Senate Health Committee Chairman Kemp Hannon on Thursday called on Attorney General Eric Schneiderman's office to investigate the hike in the cost of EpiPens after its manufacturer boosted the price in the last year by 75 percent.

If the core advice does get out there — to pediatricians, and allergists and parents — it may well keep (at least some) kids from having to grab an EpiPen after getting a whiff of peanut.

Not exact matches

Mylan drew major flak last year after news broke that it had steadily increased the list price for an EpiPen two - pack from about $ 100 to more than $ 600 in less than a decade.

Mylan saw its stock dip almost a third of a percent during after - hours trading, following members of Congress saying it cheated taxpayers by underpaying Medicaid in rebates owed on sales of its lifesaving device EpiPen.

Future tax credits could prove valuable to Mylan, which has seen sales of its flagship EpiPen allergy treatment sag after consumer outrage over the allergy treatment's $ 600 list price.

Even after the outrage the drug faced, the price of the branded EpiPen hasn't changed, Duhigg noted on a recent trip to the pharmacy, though the company did introduce a generic that has a list price of $ 300.

After all, Mylan acquired the EpiPen from another company, and while Bresch insists that significant improvements have been made to the epinephrine - delivering product itself, she also admitted on Thursday that a big part of the price increase rationale was to fund marketing and awareness efforts for the device.

Her comments came shortly after the Senate Committee on Aging asked Mylan to provide information on the reasoning behind what it called the «drastic» price increase of EpiPen, and the American Medical Association «urge [d]» Mylan to «rein in these exorbitant costs.»

Mylan, already the most dominant maker of epinephrine auto - injectors, now enjoys a near - monopoly on the market since Auvi - Q's withdrawal: After the recall, EpiPen's market share immediately jumped from 85 % to 95 % at the end of last year.

Mylan Labs (MYLN) in the hot seat after they increased the price of the life saving EpiPen.

Mylan stoked controversy this month after hiking the price of the EpiPen, commonly used to inject anti-allergens.

After widespread outrage over the soaring price of the EpiPen, Attorney General Eric Schneiderman on Tuesday announced he had launched of an anti-trust investigation into the company that manufacturers the autoinjector.

Drug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug prices.

Newman's sister called an ambulance after three EpiPens were not enough to stop her swelling.